Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 32

Trial Status

Completed5
Recruiting1

Role Distribution

Principal Investigator5
Other Roles1
PI Rate83%

Activity Timeline

Clinical Trials (6)

NCT05634876Phase 1Completed
UB-312 in Patients With Synucleinopathies
Multiple System AtrophyParkinson Disease
PrincipalinvestigatorStart date: 2023-05-31
NCT03920774Recruiting
The Natural History of Familial Dysautonomia
Familial Dysautonomia (Riley-Day Syndrome)Hereditary Sensory and Autonomic NeuropathiesHereditary Sensory and Autonomic Neuropathy 3
PrincipalinvestigatorStart date: 2017-02-22
NCT03013777Not ApplicableCompleted
A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia
Anxiety DisordersAutosomal Recessive DiseaseDysthymia+2 more
PrincipalinvestigatorStart date: 2016-12-06
NCT00004478Not ApplicableCompleted
Droxidopa in Treating Patients With Neurogenic Hypotension
Orthostatic HypotensionShy-Drager Syndrome
Studychair
NCT00633880Phase 3Completed
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more
Principalinvestigator
NCT01132326Phase 3Completed
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
Dopamine Beta Hydroxylase DeficiencyNeurogenic Orthostatic HypotensionNon-Diabetic Neuropathy+1 more
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Christopher J Mathias, MD

Imperial School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Collaborated on 1 trial
Similarity Score44%

Roy Freeman, MD

Harvard Medicine School

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Collaborated on 1 trial
Similarity Score44%

Phillip A Low, MD

Mayo Foundation

Moderately Similar
1 trials

Shared therapeutic areas:

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more

Worked with same sponsors:

Chelsea TherapeuticsChiltern International Inc.
Collaborated on 1 trial
Similarity Score44%

Italo Biaggioni, MD

Vanderbilt University

Related
15 trials

Shared therapeutic areas:

Multiple System AtrophyHypotension, OrthostaticParkinson Disease+1 more
Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Parkinson DiseaseAnxiety Disorders
Similarity Score4%

Nieto Luis

Site Coordinator of United Medical Group

Related
23 trials

Shared therapeutic areas:

Hypotension, OrthostaticParkinson Disease
Similarity Score4%

Nieto Luis, Master

Site Coordinator of United Medical Group

Related
38 trials

Shared therapeutic areas:

Parkinson DiseaseHypotension, Orthostatic
Similarity Score4%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Anxiety DisordersParkinson Disease
Similarity Score4%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Anxiety DisordersParkinson Disease
Similarity Score4%

Rangashetti Srinivasa, MD

M.S. Ramaiah Memoria Hospital, Bangalore

Related
1 trials

Shared therapeutic areas:

Parkinson Disease
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05634876Phase 1PrincipalInvestigator

UB-312 in Patients With Synucleinopathies

Multiple System AtrophyParkinson Disease
Completed
NCT03920774PrincipalInvestigator

The Natural History of Familial Dysautonomia

Familial Dysautonomia (Riley-Day Syndrome)Hereditary Sensory and Autonomic NeuropathiesHereditary Sensory and Autonomic Neuropathy 3
Recruiting
NCT03013777Not ApplicablePrincipalInvestigator

A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia

Anxiety DisordersAutosomal Recessive DiseaseDysthymia+2 more
Completed
NCT00004478Not ApplicableStudyChair

Droxidopa in Treating Patients With Neurogenic Hypotension

Orthostatic HypotensionShy-Drager Syndrome
Completed
NCT00633880Phase 3PrincipalInvestigator

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Dopamine Beta Hydroxylase DeficiencyNon-diabetic NeuropathyPrimary Autonomic Failure+1 more
Completed
NCT01132326Phase 3PrincipalInvestigator

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)

Dopamine Beta Hydroxylase DeficiencyNeurogenic Orthostatic HypotensionNon-Diabetic Neuropathy+1 more
Completed

All 6 trials loaded